Magi Drug
| Magi Drug | |
|---|---|
| Term | Magi Drug |
| Short definition | Oropharyngeal cancer - (pronounced) (OR-oh-fuh-RIN-jee-ul-KAN-ser) Cancer that forms in the tissues of the oropharynx (the part of the throat at the back of the mouth, including the soft palate, base of the tongue and tonsils). Most oropharyngeal cancers are squamous cell carcinomas (cancer that begins in flat cells lining the oropharynx) |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Magi Drug - (pronounced) (OR fun. . . ) drug used to treat, prevent, or diagnose a rare disease. A rare disease is a rare disease or condition that affects fewer than 200,000 people in the United States. Rare diseases are often serious or life-threatening. In 1983, the US government passed legislation called the Orphan Drug Act to provide pharmaceutical companies with certain financial benefits for developing orphan drugs that are safe and effective
External links
- Medical encyclopedia article on Magi Drug
- Wikipedia's article - Magi Drug
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski